She can feel great. Her pregnancy can look completely normal. But could an invisible risk be hiding in her blood? We’re following one sample to see how scientists are trying to identify preterm birth risk before symptoms begin.
For many expecting mothers, the risk of spontaneous preterm birth isn’t obvious. A pregnancy can appear healthy, a mother can have no previous complications and in the case of a first-time mom, there may be no obstetric history at all. Yet Sera Prognostics says roughly half of spontaneous preterm births occur among women considered low-risk with no established risk factors.
In this segment, we travel to Salt Lake City, Utah, and inside Sera Prognostics’ clinical laboratory to follow the journey of a mother’s blood sample. The PreTRM® Test uses protein biomarkers from a sample collected between 18 and 21 weeks of a singleton pregnancy to assess a woman’s individual risk for spontaneous preterm birth. Viewers see how scientists measure two proteins, IGFBP4 and SHBG, to help make an otherwise invisible risk visible.
The takeaway for expecting families is simple: don’t wait for symptoms to start asking about preterm birth risk. Talk with your healthcare provider early in pregnancy so that, if appropriate, testing can occur during the critical 18-to-21-week window.







